Related Experiment Videos
Diclofenac does not modify methadone bioavailability in cancer patients
Journal of Pain and Symptom Management
|April 16, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lateral gain is impaired in macular degeneration and can be targeted to restore vision in mice.
Nature communications·2022
Co-infections among COVID-19 adult patients admitted to intensive care units: results from a retrospective study.
Annali di igiene : medicina preventiva e di comunita·2022
Implementing an Integrated Palliative Care Pathway in Long-Term Care Facilities.
Journal of pain and symptom management·2026
Dyadic Coping and Illness Management among Postoperative Breast Cancer Patients and Their Spouses: An actor-partner interdependence model.
Journal of pain and symptom management·2026
Narrative Review of the US Specialty Palliative Nursing Workforce 2025: Measurement for Now and the Future.
Journal of pain and symptom management·2026
Opioid consumption and unmet need in China, 2013-2024: a longitudinal national study.
Journal of pain and symptom management·2026
Palliative Care and EOL Care Utilization in Hospitalized Adults of Dharmic Religions with Cancer.
Journal of pain and symptom management·2026
Clinical decision support for service coverage of AYA palliative care: an interrupted time series.
Journal of pain and symptom management·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026